SG3 Management’s Cardinal Health CAH Stock Holding History

SG3 Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-22,300	Closed	-$1.82M	–	222
2017 Q1	$1.82M	Buy	+22,300	New	+$1.76M	0.33%	63

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SG3 Management's CAH Position: Q2 2021 in Review

SG3 Management sold out of Cardinal Health (CAH) in Q2 2021, closing a stake of 32,500 shares — an estimated $1.97M sold.

SG3 Management first reported a position in CAH in Q2 2019 and held it in 8 quarters. The position peaked at $1.97M in Q1 2021. 789 funds tracked by Wall St. Rank hold CAH as of Q2 2021.

SG3 Management reported no remaining Cardinal Health position as of Q2 2021 after selling out during the quarter.
SG3 Management sold 32,500 Cardinal Health shares in Q2 2021, an estimated $1.97M.
SG3 Management first reported a position in Cardinal Health in Q2 2019 and held it in 8 quarters.
SG3 Management's Cardinal Health position peaked at $1.97M in Q1 2021.
789 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2021.

Based on SG3 Management's 13F filing for Q2 2021, filed 16 Aug 2021.